Johnson & Johnson (JNJ) Notes Payables (2009 - 2026)

Johnson & Johnson has disclosed Notes Payables across 18 years of filings, most recently posting $11.7 billion for Q2 2026.

• In Q2 2026, Notes Payables rose 1.44% year-over-year to $11.7 billion; the TTM figure through Jun 2026 stood at $11.7 billion (up 1.44% YoY), while the FY2025 annual figure was $8.5 billion, up 41.99% from the prior year.
• Notes Payables came in at $11.7 billion for Q2 2026 at Johnson & Johnson, down from $17.5 billion in the prior quarter.
• In the past five years, Notes Payables ranged from a high of $18.0 billion in Q2 2023 to a low of $3.5 billion in Q4 2023.
• Average Notes Payables over 5 years is $8.7 billion, with a median of $8.5 billion recorded in 2025.
• The largest YoY upside for Notes Payables was 318.41% in 2023 against a maximum downside of 72.95% in 2023.
• Over 5 years, Notes Payables stood at $4.4 billion in 2022, then retreated by 21.99% to $3.5 billion in 2023, then surged by 73.37% to $6.0 billion in 2024, then jumped by 41.99% to $8.5 billion in 2025, then surged by 37.63% to $11.7 billion in 2026.
• Per Business Quant data, the three most recent Notes Payables figures were $11.7 billion in Q2 2026, $17.5 billion in Q1 2026, and $8.5 billion in Q4 2025.